Phathom Pharmaceuticals (PHAT) Institutional Ownership
13F filers reported holding 87.8% of Phathom Pharmaceuticals (PHAT) shares as of Sep 30, 2026, across 164 filers.
- Held by 13F filers
- 87.8%
- Sep 30, 2026
- 13F filers
- 164
- quarter ended Sep 30, 2026
- 13F value
- $521.1M
- 71.4M shares
- Quarter's fund flow
- Mild accumulation
- 26 new · 25 closed
Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.
| Date | Name | Role | Type | Shares | Price** | SEC filing |
|---|---|---|---|---|---|---|
| Oct 6, 2026 | Narula Sanjeev | Chief Financial & Bus. Officer | Disposed · Tax withholding | 13,485 | $6.78 | ↗ |
| Sep 3, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Disposed · Tax withholding | 460 | $9.05 | ↗ |
| Jul 14, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Disposed · Tax withholding | 1,555 | $11.04 | ↗ |
| May 22, 2026 | Parikh Asit | director | Disposed · Gift | 28,000 | — | ↗ |
| May 22, 2026 | Parikh Asit | director | Acquired · Gift | 28,000 | — | ↗ |
| May 20, 2026 | Parikh Asit | director | Acquired · Option exercise | 17,500 | $4.95 | ↗ |
| May 20, 2026 | Parikh Asit | director | Disposed · Disposition to issuer | 17,500 | — | ↗ |
| May 19, 2026 | Parikh Asit | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | Topper James N | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | Stenhouse Mark | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | FIELDS HEIDI | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | COLA MICHAEL F | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | KARBE FRANK | director | Acquired · Grant / award | 24,122 | — | ↗ |
| May 19, 2026 | Schroeder Theodore R | director | Acquired · Grant / award | 24,122 | — | ↗ |
| Mar 10, 2026 | Parikh Asit | director | Disposed · Gift | 40,000 | — | ↗ |
| Mar 10, 2026 | Parikh Asit | director | Acquired · Gift | 40,000 | — | ↗ |
| Feb 27, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Acquired · Grant / award | 13,000 | — | ↗ |
| Feb 27, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Acquired · Grant / award | 2,790 | — | ↗ |
| Feb 27, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Disposed · Tax withholding | 964 | $12.56 | ↗ |
| Feb 27, 2026 | Breedlove Robert Charles | Principal Accounting Officer | Disposed · Tax withholding | 414 | $12.56 | ↗ |
* Holdings as reported for Sep 30, 2026, 50 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.
** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.
Common questions
How much of Phathom Pharmaceuticals do institutions hold?
13F filers reported holding 87.8% of Phathom Pharmaceuticals' shares as of Sep 30, 2026, across 164 filers.
How many 13F filers hold Phathom Pharmaceuticals?
Phathom Pharmaceuticals was held by 164 13F filers as of Sep 30, 2026.
Not investment advice.

